SCM
GSK icon

Stordahl Capital Management’s GSK GSK Stock Holding History

Stordahl Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,257
Closed -$232K – 50
2022
Q2 		$232K Hold
4,257
– – 0.09% 47
2022
Q1 		$232K Sell
4,257
-80
-2% -$4.34K 0.09% 50
2021
Q4 		$239K Hold
4,337
– – 0.09% 47
2021
Q3 		$207K Buy
+4,337
New +$218K 0.08% 47

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Stordahl Capital Management's GSK Position: Q3 2022 in Review

Stordahl Capital Management sold out of GSK (GSK) in Q3 2022, closing a stake of 4,257 shares — an estimated $232K sold.

Stordahl Capital Management first reported a position in GSK in Q3 2021 and held it in 4 quarters. The position peaked at $239K in Q4 2021. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • Stordahl Capital Management reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
  • Stordahl Capital Management sold 4,257 GSK shares in Q3 2022, an estimated $232K.
  • Stordahl Capital Management first reported a position in GSK in Q3 2021 and held it in 4 quarters.
  • Stordahl Capital Management's GSK position peaked at $239K in Q4 2021.
  • 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Stordahl Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.